Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-10

FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for LEVOTHYROXINE SODIUM (Teva Pharmaceuticals, Inc.). The approval concerns changes to the product labeling for this th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)